<p>The biocompatibility of ATV-BSA nanoparticles is shown with tubes from left to right as: PC-Positive control, NC-Negative Control, a to c, d to f and g to i showing the biocompatibility of 10,15 & 20 µg/mL concentrations of ATV, BSA and ATV-BSA nanoparticles in RBC's respectively.</p
Hemolysis testing is the most common method to determine the hemocompatibility properties of biomate...
Abstract Biosensors based on nanotechnology are developing rapidly and are widely applied in many fi...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do...
<p>Hemolytic curves for human RBC/NP:RBCs were obtained after the addition of complement obtain from...
<p>Cytotoxicity of BSA nanoparticles, ATV & ATV-BSA nanoparticles at equal concentrations as measure...
Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and ...
The potential use of nanomaterials in medicine offers opportunities for novel therapeutic approaches...
<div><p>Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound dr...
<p>Three different concentrations of the test samples were added to the cells and incubated for 24 h...
International audienceThis contribution investigates the interaction of two types of biomimetic-apat...
<p>Percent hemolysis of mouse (A,B,C) and human (D,E) RBC/NP:RBCs (50:1; 200:1; and 2000:1) were obt...
Nanoparticles (NPs) in biotechnology hold great promise for revolutionizing medical treatments and t...
<p>Biocompatibility of Mag@SiO2 nanoparticles assessed using MTT assay after their exposure to PC3 c...
An emerging interest regarding nanoparticles (NPs) concerns their potential immunomodulatory and pro...
The development of drug nanocarriers based on polymeric, lipid and ceramic biomaterials has been pav...
Hemolysis testing is the most common method to determine the hemocompatibility properties of biomate...
Abstract Biosensors based on nanotechnology are developing rapidly and are widely applied in many fi...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do...
<p>Hemolytic curves for human RBC/NP:RBCs were obtained after the addition of complement obtain from...
<p>Cytotoxicity of BSA nanoparticles, ATV & ATV-BSA nanoparticles at equal concentrations as measure...
Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and ...
The potential use of nanomaterials in medicine offers opportunities for novel therapeutic approaches...
<div><p>Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound dr...
<p>Three different concentrations of the test samples were added to the cells and incubated for 24 h...
International audienceThis contribution investigates the interaction of two types of biomimetic-apat...
<p>Percent hemolysis of mouse (A,B,C) and human (D,E) RBC/NP:RBCs (50:1; 200:1; and 2000:1) were obt...
Nanoparticles (NPs) in biotechnology hold great promise for revolutionizing medical treatments and t...
<p>Biocompatibility of Mag@SiO2 nanoparticles assessed using MTT assay after their exposure to PC3 c...
An emerging interest regarding nanoparticles (NPs) concerns their potential immunomodulatory and pro...
The development of drug nanocarriers based on polymeric, lipid and ceramic biomaterials has been pav...
Hemolysis testing is the most common method to determine the hemocompatibility properties of biomate...
Abstract Biosensors based on nanotechnology are developing rapidly and are widely applied in many fi...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do...
DOI
Add to ORKG